Hargart, F: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

Assembly of a conduct risk regulatory model for developing market banks

Hargarter, Antje, Van Vuuren, Gary

Journal:

South African Journal of Economic and Management Sciences

Year:

2017

Language:

english

File:

PDF, 2.30 MB

english, 2017

2

Transition from immediate-release methylphenidate (ir-mph) to extended-release methylphenidate (OROS®-MPH) improves quality of life of patients with adhd -a naturalistic study

L. Hargarter, M. Gerwe, J. Czekalla, F. Mattejat

Journal:

European Psychiatry

Year:

2007

Language:

english

File:

PDF, 45 KB

english, 2007

3

Signatures of single-photon interaction between two quantum dots located in different cavities of a weakly coupled double microdisk structure

Seyfferle, S., Hargart, F., Jetter, M., Hu, E., Michler, P.

Journal:

Physical Review B

Year:

2018

Language:

english

File:

PDF, 1023 KB

english, 2018

4

Clinical relevance of paliperidone palmitate 3-monthly in treating schizophrenia

Mathews, Maju, Gopal, Srihari, Nuamah, Isaac, Hargarter, Ludger, Savitz, Adam J, Kim, Edward, Tan, Wilson, Soares, Bernardo, Correll, Christoph U

Journal:

Neuropsychiatric Disease and Treatment

Year:

2019

Language:

english

File:

PDF, 398 KB

english, 2019

5

Mechanical properties of glass fiber/talc/polybutylene-terephthalate composites as processed by the radlite technique

Nicole Hargarter, Klaus Friedrich, Peter Catsman

Journal:

Composites Science and Technology

Year:

1993

Language:

english

File:

PDF, 1.44 MB

english, 1993

6

Effects of preferentially aligned precipitates on plastic anisotropy in Al-Cu-Mg-Ag and Al-Cu alloys

H. Hargarter, M.T. Lyttle, E.A. Starke

Journal:

Materials Science and Engineering: A

Year:

1998

Language:

english

File:

PDF, 1.45 MB

english, 1998

7

Improved functionality, health related quality of life and decreased burden of disease in patients with ADHD treated with OROS®MPH: is treatment response different between children and adolescents?

Michael Berek, Andreas Kordon, Ludger Hargarter, Fritz Mattejat, Lara Slawik, Klaus Rettig, Barbara Schäuble

Journal:

Child and Adolescent Psychiatry and Mental Health

Year:

2011

Language:

english

File:

PDF, 314 KB

english, 2011

8

Zur Kenntnis der Phasenverhältnisse im System FeTiO bei 1000 °C

N. G. Schmahl, B. Frisch, E. Hargarter

Journal:

Zeitschrift für anorganische und allgemeine Chemie

Year:

1960

Language:

german

File:

PDF, 740 KB

german, 1960

9

Behandlung mit Methylphenidat im Kindesalter

J.M. Fegert, H. Bode, I. Hach, L. Hargarter, W.E. Müller

Journal:

Monatsschrift Kinderheilkunde

Year:

2007

Language:

german

File:

PDF, 430 KB

german, 2007

10

Strong antibunching from electrically driven devices with long pulses: A regime for quantum-dot single-photon generation

Kessler, C. A., Reischle, M., Hargart, F., Schulz, W.-M., Eichfelder, M., Roßbach, R., Jetter, M., Michler, P., Gartner, P., Florian, M., Gies, C., Jahnke, F.

Journal:

Physical Review B

Year:

2012

Language:

english

File:

PDF, 685 KB

english, 2012

11

Long-term adherence and health outcomes study with risperdal consta and oral atypicals in the treatment of schizophrenia patients (interim-analysis RIS-SCH-4023)

J. Czekalla, B. Ibach, L. Hargarter, M. Gerwe

Journal:

European Psychiatry

Year:

2007

Language:

english

File:

PDF, 54 KB

english, 2007

12

Time to clinical stabilization and discharge from hospital treatment of patients with schizophrenia after conversion to long-acting risperidone (RIS-CONSTA), ris-siv-401

B. Ibach, L. Hargarter, M. Gerwe, J. Czekalla

Journal:

European Psychiatry

Year:

2007

Language:

english

File:

PDF, 54 KB

english, 2007

13

Evaluating decision criteria for the choice of pharmacological long-term therapy in risperidone treated patients with schizophrenia

B. Ibach, M. Gerwe, L. Hargarter

Journal:

European Psychiatry

Year:

2008

Language:

english

File:

PDF, 41 KB

english, 2008

14

P.7.c.007 Changes in quality of life after transition from immediate release methylphenidate (IR-MPH) to controlled-release MPH in patients with ADHD

B. Schauble, F. Mattejat, L. Hargarter

Journal:

European Neuropsychopharmacology

Year:

2007

Language:

english

File:

PDF, 58 KB

english, 2007

15

P.3.a.017 Do attitudes towards medication adherence in schizophrenia vary between stakeholders? A comparison of survey results

L. Hargarter, R. Emsley, K. Alptekin, F. Cañas, P. Gorwood, D. Naber, J.M. Olivares, G. Papageorgiou, K. Jones, A. Schreiner

Journal:

European Neuropsychopharmacology

Year:

2012

Language:

english

File:

PDF, 71 KB

english, 2012

16

PMH7 PREVALENCE OF POTENTIAL MEDICATION INTERACTIONS WITH ANTIPSYCHOTICS VIA CYTOCHROME P450 IN PATIENTS WITH SCHIZOPHRENIA IN GERMANY

A Mehnert, L Hargarter, J Diels

Journal:

Value in Health

Year:

2008

Language:

english

File:

PDF, 69 KB

english, 2008

17

PMH6 Effectiveness of Long-Acting Iinjectable Risperidone and Oral Atypical Antipsychotics in a 24-Months Observational Study in Adult Patients with Schizophrenia in Germany

L. Hargarter, J. Fleischmann, J. Diels, J. Rabinowitz, M. Hemels, M. Gaudig, S. Van sanden, A. Schreiner

Journal:

Value in Health

Year:

2011

Language:

english

File:

PDF, 58 KB

english, 2011

18

Validation of the Personal and Social Performance (PSP) Scale in a German sample of acutely ill patients with schizophrenia

Georg Juckel, Daniela Schaub, Nina Fuchs, Ute Naumann, Idun Uhl, Henning Witthaus, Ludger Hargarter, Hans-Werner Bierhoff, Martin Brüne

Journal:

Schizophrenia Research

Year:

2008

Language:

english

File:

PDF, 296 KB

english, 2008

19

Poster #185 THE EMEA ADHES SURVEY IN SCHIZOPHRENIA: NURSES’ PERCEPTIONS OF THE EXTENT AND BURDEN OF PARTIAL AND NON-ADHERENCE TO MEDICATION IN PATIENTS WITH SCHIZOPHRENIA

R. Emsley, K. Alptekin, J.-M. Azorin, F. Cañas, V. Dubois, P. Gorwood, D. Naber, J.M. Olivares, G. Papageorgiou, M. Roca, P. Thomas, L. Hargarter, A. Schreiner

Journal:

Schizophrenia Research

Year:

2012

Language:

english

File:

PDF, 94 KB

english, 2012

20

Poster #184 THE EMEA ADHES SURVEY: SCHIZOPHRENIA THROUGH THE CARERS’ EYES

A. Svettini, B. Johnson, C. Magro, J. Saunders, K. Jones, S. Silk, L. Hargarter, A. Schreiner

Journal:

Schizophrenia Research

Year:

2012

Language:

english

File:

PDF, 71 KB

english, 2012

21

Poster #186 THE EMEA ADHES SURVEY IN SCHIZOPHRENIA: NURSES’ VIEWS ON THE TREATMENT OPTIONS FOR IMPROVING PARTIAL OR NON-ADHERENCE IN PATIENTS WITH SCHIZOPHRENIA

R. Emsley, K. Alptekin, J.-M. Azorin, F. Cañas, V. Dubois, P. Gorwood, D. Naber, J.M. Olivares, G. Papageorgiou, M. Roca, P. Thomas, L. Hargarter, A. Schreiner

Journal:

Schizophrenia Research

Year:

2012

Language:

english

File:

PDF, 70 KB

english, 2012

22

Poster #171 PSYCHIATRISTS' PERCEPTIONS OF THE CLINICAL IMPORTANCE, ASSESSMENT AND MANAGEMENT OF PATIENT FUNCTIONING IN THE TREATMENT OF SCHIZOPHRENIA: RESULTS OF AN EMEA-WIDE SURVEY

Philip Gorwood, Georg Juckel, Tom Burns, Alessandro Rossi, Luis San, Pierre Cherubin, Ludger Hargarter, Andreas Schreiner

Journal:

Schizophrenia Research

Year:

2012

Language:

english

File:

PDF, 64 KB

english, 2012

23

Quantum key distribution using quantum dot single-photon emitting diodes in the red and near infrared spectral range

Heindel, Tobias, Kessler, Christian A, Rau, Markus, Schneider, Christian, Fürst, Martin, Hargart, Fabian, Schulz, Wolfgang-Michael, Eichfelder, Marcus, Roßbach, Robert, Nauerth, Sebastian, Lermer, Mat

Journal:

New Journal of Physics

Year:

2012

Language:

english

File:

PDF, 1.13 MB

english, 2012

24

High-power InP quantum dot based semiconductor disk laser exceeding 1.3 W

Schwarzbäck, T., Bek, R., Hargart, F., Kessler, C. A., Kahle, H., Koroknay, E., Jetter, M., Michler, P.

Journal:

Applied Physics Letters

Year:

2013

Language:

english

File:

PDF, 890 KB

english, 2013

25

P03-46 - Long-term safety, tolerability and efficacy of risperidone long-acting injectable and oral atypical antipsychotics in schizophrenic patients: two year naturalistic study

Ibach, B., Rabinowitz, J., Schreiner, A., Hargarter, L., Diekamp, B.

Journal:

European Psychiatry

Year:

2010

Language:

english

File:

PDF, 34 KB

english, 2010

26

Poster #T87 ONCE MONTHLY PALIPERIDONE PALMITATE – TOLERABILITY AND TREATMENT RESPONSE IN RECENTLY DIAGNOSED VERSUS CHRONIC NON-ACUTE SCHIZOPHRENIA PATIENTS SWITCHED FROM PREVIOUSLY UNSUCCESSFUL TREATMENT WITH ORAL ANTIPSYCHOTICS

Hargarter, Ludger, Bergmans, Paul, Cherubin, Pierre, Rancans, Elmars, Bez, Yasin, Parellada, Eduardo, Carpiniello, Bernardo, Vidailhet, Pierre, Schreiner, Andreas

Journal:

Schizophrenia Research

Year:

2014

Language:

english

File:

PDF, 92 KB

english, 2014

27

Poster #T209 FLEXIBLY DOSED PALIPERIDONE PALMITATE IN NON-ACUTE BUT SYMPTOMATIC PATIENTS WITH SCHIZOPHRENIA PREVIOUSLY UNSUCCESSFULLY TREATED WITH LONG-ACTING INJECTABLE RISPERIDONE

Schreiner, Andreas, Bergmans, Paul, Llorca, Pierre-Michel, Corrivetti, Giulio, Cosar, Behcet, Cherubin, Pierre, Hargarter, Ludger

Journal:

Schizophrenia Research

Year:

2014

Language:

english

File:

PDF, 91 KB

english, 2014

28

Poster #S248 FLEXIBLY DOSED PALIPERIDONE PALMITATE IN NON-ACUTE PATIENTS WITH SCHIZOPHRENIA PREVIOUSLY UNSUCCESSFULLY TREATED WITH CONVENTIONAL DEPOT ANTIPSYCHOTICS

Schreiner, Andreas, Hargarter, Ludger, Llorca, Pierre-Michel, Cosar, Behcet, Petralia, Antonino, Bergmans, Paul, Cherubin, Pierre

Journal:

Schizophrenia Research

Year:

2014

Language:

english

File:

PDF, 110 KB

english, 2014

29

Poster #T210 PALIPERIDONE PALMITATE IN ACUTE PATIENTS WITH SCHIZOPHRENIA – TREATMENT RESPONSE, SAFETY AND TOLERABILITY: A PROSPECTIVE FLEXIBLE DOSE STUDY IN PATIENTS PREVIOUSLY UNSUCCESSFULLY TREATED WITH ORAL ANTIPSYCHOTICS

Schreiner, Andreas, Bergmans, Paul, Cherubin, Pierre, Rancans, Elmars, Bez, Yasin, Parellada, Eduardo, Carpiniello, Bernado, Vidailhet, Pierre, Hargarter, Ludger

Journal:

Schizophrenia Research

Year:

2014

Language:

english

File:

PDF, 92 KB

english, 2014

30

Amélioration fonctionnelle sous palmitate de paliperidone à doses flexibles chez des patients aigus ou non aigus atteints de schizophrénie, après échec d’un traitement par antipsychotiques oraux

Hargarter, L., Bergmans, B., Cherubin, P., Bjorner, A., Knegtering, H., Parellada, E., Carpiniello, B., Vidailhet, P., Mertens, C., Schreiner, A.

Journal:

European Psychiatry

Year:

2013

Language:

french

File:

PDF, 58 KB

french, 2013

31

Poster #M228 FLEXIBLY DOSED PALIPERIDONE PALMITATE IN NON-ACUTE PATIENTS WITH SCHIZOPHRENIA SWITCHED FROM PREVIOUSLY UNSUCCESSFUL MONOTHERAPY WITH ORAL ATYPICAL ANTIPSYCHOTICS

Hargarter, Ludger, Bergmans, Paul, Cherubin, Pierre, Rancans, Elmars, Bez, Yasin, Parellada, Eduardo, Carpiniello, Bernado, Vidailhet, Pierre, Schreiner, Andreas

Journal:

Schizophrenia Research

Year:

2014

Language:

english

File:

PDF, 112 KB

english, 2014

32

Treatment with OROS®-Methylphenidate in adolescents is associated with an improvement in functioning and quality of life - A post-hoc analysis

Kordon, A., Ancker, U., Schlueter, D., Hargarter, L., Mattejat, F., Schauble, B.

Journal:

European Psychiatry

Year:

2008

Language:

english

File:

PDF, 48 KB

english, 2008

33

1100 – Safety, tolerability and treatment response with flexible doses of paliperidone palmitate in patients with an acute exacerbation of schizophrenia

Schreiner, A., Hargarter, L., Bergmans, P., Cherubin, P.

Journal:

European Psychiatry

Year:

2013

Language:

english

File:

PDF, 43 KB

english, 2013

34

P-1241 - Nurses' perceptions of assessment, causes and management of partial/non-adherence to medication: results of the EMEA adhes survey in schizophrenia

Emsley, R., Alptekin, K., Azorin, J.-M., Canas, F., Dubois, V., Gorwood, P., Naber, D., Olivares, J.M., Papageorgiou, G., Roca, M., Thomas, P., Hargarter, L., Schreiner, A.

Journal:

European Psychiatry

Year:

2012

Language:

english

File:

PDF, 69 KB

english, 2012

35

Poster #M243 PALIPERIDONE PALMITATE – IMPACT ON NEGATIVE DISORGANIZED AND DEPRESSIVE SYMPTOMS SUBJECTIVE WELL-BEING AND PATIENT SATISFACTION IN PATIENTS WITH SCHIZOPHRENIA PREVIOUSLY UNSUCCESSFULLY TREATED WITH ORAL ANTIPSYCHOTICS

Schreiner, Andreas, Hargarter, Ludger, Bergmans, Paul, Cherubin, Pierre, Rancans, Elmars, Bez, Yasin, Parellada, Eduardo, Carpiniello, Bernardo, Vidailhet, Pierre

Journal:

Schizophrenia Research

Year:

2014

Language:

english

File:

PDF, 92 KB

english, 2014

36

OROS®-MPH in adolescents with ADHD transitioning from Atomoxetine or ER-MPH (medikinet retard®) - a post-hoc analysis

Adam, A., Haertling, F., Bogdanow, M., Mattejat, F., Hargarter, L., Schauble, B.

Journal:

European Psychiatry

Year:

2008

Language:

english

File:

PDF, 46 KB

english, 2008

37

1096 – Safety, tolerability and treatment response with flexible doses of paliperidone palmitate in non-acute patients with schizophrenia

Schreiner, A., Hargarter, L., Bergmans, P., Cherubin, P.

Journal:

European Psychiatry

Year:

2013

Language:

english

File:

PDF, 43 KB

english, 2013

38

P-1242 - Schizophrenia through the carers’ eyes: results of a european survey

Svettini, A., Johnson, B., Magro, C., Saunders, J., Jones, K., Silk, S., Hargarter, L., Schreiner, A.

Journal:

European Psychiatry

Year:

2012

Language:

english

File:

PDF, 67 KB

english, 2012

39

LONG-TERM SAFETY, TOLERABILITY AND EFFICACY OF RISPERIDONE LONG-ACTING INJECTABLE AND ORAL ATYPICAL ANTIPSYCHOTICS IN SCHIZOPHRENIC PATIENTS: TWO YEAR NATURALISTIC STUDY

Ibach, Bernd, Rabinowitz, Jonathan, Schreiner, Andreas, Hargarter, Ludger, Diekamp, Bettina

Journal:

Schizophrenia Research

Year:

2010

Language:

english

File:

PDF, 65 KB

english, 2010

40

P03-45 - Psychosocial functioning of schizophrenic patients in post-acute treatment with long-acting injectable risperidone in ambulatory care

Juckel, G., Diekamp, B., Ibach, B., Hargarter, L.

Journal:

European Psychiatry

Year:

2010

Language:

english

File:

PDF, 32 KB

english, 2010

41

Changes in quality of life in ADHD-patients treated with extended-release Methylphenidate (OROS®-MPH) - results from an open-label naturalistic study

Mitt, C., Arend, W., Schauble, B., Hargarter, L., Mattejat, F.

Journal:

European Psychiatry

Year:

2008

Language:

english

File:

PDF, 46 KB

english, 2008

42

PW01-178 - Effectiveness, tolerability and compliance of schizophrenic patients under treatment with oral atypical antipsychotics or long-acting injectable risperidone in daily routine

Schreiner, A., Ibach, B., Hargarter, L., Diekamp, B.

Journal:

European Psychiatry

Year:

2010

Language:

english

File:

PDF, 32 KB

english, 2010

43

P03-44 - Effectiveness of long-acting injectable risperidone in the post-acute treatment of schizophrenic patients in ambulatory care

Hargarter, L., Diekamp, B., Ibach, B., Juckel, G.

Journal:

European Psychiatry

Year:

2010

Language:

english

File:

PDF, 28 KB

english, 2010

44

P-1243 - Psychiatrists' perceptions of the clinical importance, assessment and management of functioning: results of the EMEA survey in schizophrenia

Gorwood, P., Juckel, G., Burns, T., Rossi, A., San, L., Cherubin, P., Hargarter, L., Schreiner, A.

Journal:

European Psychiatry

Year:

2012

Language:

english

File:

PDF, 68 KB

english, 2012

45

Poster #S247 A RANDOMIZED, ACTIVE-CONTROLLED RATER-BLINDED 2-YEAR STUDY OF PALIPERIDONE PALMITATE VERSUS INVESTIGATORS' CHOICE OF ORAL ANTIPSYCHOTIC MONOTHERAPY IN PATIENTS WITH SCHIZOPHRENIA (PROSIPAL)

Schreiner, Andreas, Aadamsoo, Kaire, Altamura, Carlo, Franco, Manuel, Gorwood, Philip, Neznanov, Nikolay G., Schronen, Juan, Üçok, Alp, Zink, Mathias, Lahaye, Marjolein, Hargarter, Ludger

Journal:

Schizophrenia Research

Year:

2014

Language:

english

File:

PDF, 93 KB

english, 2014

46

Clinical effectiveness and resource utilization of paliperidone ER for schizophrenia: Pharmacoepidemiologic International Longitudinal Antipsychotic Registry (PILAR)

Schreiner, A., Hargarter, L., Hitschfield, K., Lee, J.I., Lenskaya, I., Sulaiman, A.H., Diels, J.

Journal:

Current Medical Research and Opinion

Year:

2014

Language:

english

File:

PDF, 587 KB

english, 2014

47

EPA-1549 - A randomized, active-controlled rater-blinded 2-year study of paliperidone palmitate versus investigators’ choice of oral antipsychotic monotherapy in patients with schizophrenia (prosipal)

Schreiner, A., Aadamsoo, K., Altamura, A.C., Franco, M., Goorwood, P., Neznanov, N.G., Schronen, J., Ucok, A., Zink, M., Cherubin, P., Lahaye, M., Hargarter, L.

Journal:

European Psychiatry

Year:

2014

Language:

english

File:

PDF, 69 KB

english, 2014

48

EPA-1546 - Paliperidone palmitate in non-acute but symptomatic patients with schizophrenia previously unsuccessfully treated with oral aripiprazole

Hargarter, L., Bergmans, P., Cherubin, P., Rancans, E., Bez, Y., Parellada, E., Carpiniello, B., Vidailhet, P., Schreiner, A.

Journal:

European Psychiatry

Year:

2014

Language:

english

File:

PDF, 68 KB

english, 2014

49

EPA-1545 - Functional outcomes with once-monthly paliperidone palmitate in acute and in non-acute patients with schizophrenia previously unsuccessfully treated with oral antipsychotics

Hargarter, L., Bergmans, P., Cherubin, P., Björner, A., Knegtering, R., Parellada, E., Carpiniello, B., Vidailhet, P., Mertens, C., Schreiner, A.

Journal:

European Psychiatry

Year:

2014

Language:

english

File:

PDF, 59 KB

english, 2014

50

EPA-1548 - Flexibly dosed paliperidone palmitate in non-acute patients with schizophrenia switched from previously unsuccessful monotherapy with oral atypical antipsychotics

Hargarter, L., Bergmans, P., Cherubin, P., Rancans, E., Bez, Y., Parellada, E., Carpiniello, B., Vidailhet, P., Schreiner, A.

Journal:

European Psychiatry

Year:

2014

Language:

english

File:

PDF, 69 KB

english, 2014